Navigation Links
Researchers compare different systems of measuring treatment intensity in hypertension care
Date:6/17/2009

(Boston)- It is known that more intensive management of hypertension can improve blood pressure control and thus improve cardiovascular outcomes. However, there are several different systems of measuring the intensity of management of hypertension, and they have not been previously compared. If one system performs best, it would be important to use it to measure intensity of management for research and quality improvement purposes. Researchers from Boston University have compared different measures of treatment intensity in hypertension care and have found that one of the measures should be preferred to the others. This study, which appears in the July issue of Circulation: Cardiovascular Quality and Outcomes, shows that the measure originally described by Okonofua, et al. (Hypertension, 2006) predicts blood pressure control more effectively than the other two measures studied.

Eight hundred nineteen hypertensive outpatients were characterized with three different scores to measure treatment intensity over time. The first examined whether a patient had any-or-none medication increases. The second approach was a norm-based method, which models the chance of a medication increase at each visit and then scores each patient based on whether they received more or fewer medication increases then predicted. The third approach was a standard-based method, which is similar to the norm-based method, but expects a medication increase whenever the blood pressure is uncontrolled. The researchers compared whether these three scores could predict the final systolic blood pressure and discovered that the any-or-none medication increase and the norm-based measure did not predict blood pressure, and, therefore are not valid measures of treatment intensity. However, they did find that the standard-based measure was an excellent predictor of blood pressure control.

"The norm-based method did not predict systolic blood pressure in a linear fashion. Further investigation revealed a U-shaped relationship between the norm-based score and systolic blood pressure," said lead author Adam Rose, MD, MSc, assistant professor of Medicine at BUSM and investigator at the Bedford VA Medical Center. "In contrast, the standard-based score was an excellent predictor of the final blood pressure, both in the overall population and in every subgroup that was examined. Many research and quality improvement efforts already measure or are proposing to measure treatment intensity in the care of chronic conditions, including diabetes, hypertension and hyperlipidemia."

This study is important to researchers who measure treatment intensity in the care of chronic conditions and healthcare systems that wish to measure treatment intensity for quality improvement or pay for performance programs. This study suggests that, at least with regard to hypertension care, the standard-based score should be the preferred measure.


'/>"/>

Contact: Allison Rubin
allison.rubin@bmc.org
617-638-8490
Boston University Medical Center
Source:Eurekalert

Related medicine news :

1. Jackson, Rockefeller obesity researchers share Shaw Prize
2. TGen and USC researchers find genetic markers to help fight diabetes
3. Vanderbilt researchers pioneer an advanced sepsis detection and management system
4. USC researchers identify DNA mutation that occurs at beginning point of T-cell lymphoma
5. Researchers identify 4 new targets for breast cancer
6. Researchers at Case Western Reserve discover a new way the body fights fungal infection
7. Off-label morning sickness drug deemed safe for fetuses -- Ben-Gurion U. researchers
8. Researchers identify four new targets for breast cancer
9. VBI researchers develop new method for breast cancer biomarker discovery
10. Researchers estimate risk of transmission of Huntingtons disease to offspring among male carriers
11. LSUHSC researchers first to document early signs for diabetes in kids as young as 7
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/9/2016)... ... December 09, 2016 , ... MEDI+SIGN®, a provider ... that a new solution for Emergency Departments (ED) has been added to their ... Emergency Department examination rooms, and with a simplified pallet of information available to ...
(Date:12/8/2016)... , ... December 08, 2016 , ... ... with distinction by the Undersea and Hyperbaric Medical Society (UHMS), the leading authority ... care and patient safety. Only a few hospitals and facilities have earned this ...
(Date:12/8/2016)... ... December 08, 2016 , ... Seavest ... Property owned by an affiliate of Seavest, has won a prestigious national healthcare ... Chester County ambulatory care center (ACC) was named “Best New Development, MOBs and ...
(Date:12/8/2016)... ... December 08, 2016 , ... David J. Dykeman , ... Greenberg Traurig, LLP, will speak at DeviceTalks West, Dec. 12, 2016, at the Fairmont ... and attorneys from the firm’s global Life Sciences & Medical Technology Group have been ...
(Date:12/8/2016)... ... 2016 , ... Catalent Pharma Solutions, the leading global provider ... products, today announced that it had joined the Pharmaceutical Supply Chain Initiative (PSCI). ... unite pharmaceutical and healthcare companies that share a vision of better, social, environmental ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... , Dec. 8, 2016 KEY FINDINGS ... the largest share of the market in 2016 and ... dominance can be attributed to a large number of ... (US hold the largest share in the patient temperature ... benefits such as reducing loss of blood during surgeries, ...
(Date:12/8/2016)... 8, 2016 Research and Markets has announced ... Trends - Adhesion Type, Application, Usability - Forecast to 2025" ... , ... Market is poised to grow at a CAGR of around 3.2% ... market is witnessing include advancements in extracellular microelectrode arrays and intracellular ...
(Date:12/8/2016)... Quebec , Dec. 8, 2016  Valeant ... and TSX: VRX) ("Valeant") today announced positive results ... clinical study to assess the safety and efficacy ... the treatment of plaque psoriasis. ... subjects with moderate to severe psoriasis, IDP-118 showed ...
Breaking Medicine Technology: